This inventor holds 1 USPTO granted patent. Top assignee: Ludwig Institute for Cancer Research Limited. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Fabienee Anjuere: Innovator in Photoreactive Peptide Derivatives
Introduction
Fabienee Anjuere is a notable inventor based in Epalinges, Switzerland. He has made significant contributions to the field of synthetic peptides, particularly through his innovative work on photoreactive peptide derivatives.
Latest Patents
Anjuere holds a patent for "Photoreactive peptide derivatives." This invention relates to methods for making synthetic, photoreactive peptides and their applications. A photoreactively labelled amino acid is incorporated into the peptide, allowing the resulting peptide to maintain its ability to bind an MHC molecule, unlike its non-labelled counterpart. He has 1 patent to his name.
Career Highlights
Fabienee Anjuere is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance research in cancer-related fields. His work is pivotal in developing new methodologies that enhance the understanding of peptide interactions in biological systems.
Collaborations
Anjuere collaborates with esteemed colleagues, including Immanuel F. Luescher and Andreas Layer, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Fabienee Anjuere's contributions to the field of photoreactive peptides exemplify the impact of innovative research in cancer biology. His work not only advances scientific knowledge but also holds potential for future therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile